Analysis of Inventory
Inventory Disclosure
Cigna Group, balance sheet: inventory
US$ in millions
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Prescription drugs and medical supplies | 6,692) | 5,645) | 4,777) | 3,722) | 3,165) | ||||||
| Inventories | 6,692) | 5,645) | 4,777) | 3,722) | 3,165) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
| Item | Description | The company |
|---|---|---|
| Inventories | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. | Cigna Group inventories increased from 2022 to 2023 and from 2023 to 2024. |